Capietto AH - Search Results

1

Phosphoantigens overcome human TCRVgamma9+ gammadelta Cell immunosuppression by TGF-beta: relevance for cancer immunotherapy.

Capietto AH, Martinet L, Cendron D, Fruchon S, Pont F, Fournié JJ. Capietto AH, et al. J Immunol. 2010 Jun 15;184(12):6680-7. doi: 10.4049/jimmunol.1000681. Epub 2010 May 17. J Immunol. 2010. PMID: 20483742

2

Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies.

Gertner-Dardenne J, Bonnafous C, Bezombes C, Capietto AH, Scaglione V, Ingoure S, Cendron D, Gross E, Lepage JF, Quillet-Mary A, Ysebaert L, Laurent G, Sicard H, Fournié JJ. Gertner-Dardenne J, et al. Among authors: capietto ah. Blood. 2009 May 14;113(20):4875-84. doi: 10.1182/blood-2008-08-172296. Epub 2009 Mar 10. Blood. 2009. PMID: 19278954 Free article.

3

Emerging concepts for the treatment of hematological malignancies with therapeutic monoclonal antibodies.

Capietto AH, Keirallah S, Gross E, Dauguet N, Laprévotte E, Jean C, Gertner-Dardenne J, Bezombes C, Quillet-Mary A, Poupot M, Ysebaert L, Laurent G, Fournié JJ. Capietto AH, et al. Curr Drug Targets. 2010 Jul;11(7):790-800. doi: 10.2174/138945010791320845. Curr Drug Targets. 2010. PMID: 20370648 Review.

4

How tumors might withstand γδ T-cell attack.

Capietto AH, Martinet L, Fournié JJ. Capietto AH, et al. Cell Mol Life Sci. 2011 Jul;68(14):2433-42. doi: 10.1007/s00018-011-0705-7. Epub 2011 May 6. Cell Mol Life Sci. 2011. PMID: 21547501 Free PMC article. Review.

5

Stimulated γδ T cells increase the in vivo efficacy of trastuzumab in HER-2+ breast cancer.

Capietto AH, Martinet L, Fournié JJ. Capietto AH, et al. J Immunol. 2011 Jul 15;187(2):1031-8. doi: 10.4049/jimmunol.1100681. Epub 2011 Jun 13. J Immunol. 2011. PMID: 21670311

6

Sources of Cancer Neoantigens beyond Single-Nucleotide Variants.

Capietto AH, Hoshyar R, Delamarre L. Capietto AH, et al. Int J Mol Sci. 2022 Sep 4;23(17):10131. doi: 10.3390/ijms231710131. Int J Mol Sci. 2022. PMID: 36077528 Free PMC article. Review.

7

Characterizing neoantigens for personalized cancer immunotherapy.

Capietto AH, Jhunjhunwala S, Delamarre L. Capietto AH, et al. Curr Opin Immunol. 2017 Jun;46:58-65. doi: 10.1016/j.coi.2017.04.007. Epub 2017 May 4. Curr Opin Immunol. 2017. PMID: 28478383 Review.

8

Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8⁺ T Cells in Murine Syngeneic Tumor Models.

Xiong H, Mittman S, Rodriguez R, Pacheco-Sanchez P, Moskalenko M, Yang Y, Elstrott J, Ritter AT, Müller S, Nickles D, Arenzana TL, Capietto AH, Delamarre L, Modrusan Z, Rutz S, Mellman I, Cubas R. Xiong H, et al. Among authors: capietto ah. Cancer Immunol Res. 2019 Jun;7(6):963-976. doi: 10.1158/2326-6066.CIR-18-0750. Epub 2019 May 7. Cancer Immunol Res. 2019. PMID: 31064777

9

Immunization associated with primary tumor growth leads to rejection of commonly used syngeneic tumors upon tumor rechallenge.

Alicke B, Totpal K, Schartner JM, Berkley AM, Lehar SM, Capietto AH, Cubas RA, Gould SE. Alicke B, et al. Among authors: capietto ah. J Immunother Cancer. 2020 Jul;8(2):e000532. doi: 10.1136/jitc-2020-000532. J Immunother Cancer. 2020. PMID: 32675310 Free PMC article.

10

Novel ERα positive breast cancer model with estrogen independent growth in the bone microenvironment.

Capietto AH, Chan SR, Ricci B, Allen JA, Su X, Novack DV, Schreiber RD, Faccio R. Capietto AH, et al. Oncotarget. 2016 Aug 2;7(31):49751-49764. doi: 10.18632/oncotarget.10443. Oncotarget. 2016. PMID: 27391074 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters